NCCN Pharmacy Updates: Understanding the Molecular Heterogeneity of Diffuse Large B-Cell Lymphomas and the Place of Targeted Therapies in Treatment
New promising combinations of chemoimmunotherapy with antibody drug conjugates, and small molecule inhibitors may offer an alternative approach for patients with relapsed or refractory disease. Many of these new therapies are oral and will be managed by a multidisciplinary team.
Monthly Oncology Tumor Boards: Advances in Multidisciplinary Management of Acute Myeloid Leukemia
Clinicians need to be informed about therapeutic advances and necessary supportive care precautions to aid in their effective and safe incorporation into clinical practice for the appropriate AML patient subpopulations.
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Colon Cancer
Education is needed to help guide clinicians on appropriate biomarker testing for patients with mCRC and how the results of these tests can aid in treatment decision-making in this rapidly evolving landscape. Optimal treatment strategies can maximize benefits while minimizing harms, giving patients with mCRC the best quality and quantity of life possible.
Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (3/25/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

NCCN 2021 Virtual Annual Conference

The NCCN 2021 Annual Conference is designed to fill real and important medical educational needs of cancer care providers to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.

NCCN 2021 Virtual Oncology Fellows Program: New Horizons in Quality Cancer Care
The goal of this program is to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and other evidence-based treatment principles in the management of significant cancer types, and supportive care and professional development issues.
NCCN 2021 Virtual Nursing Program: Advancing Oncology Nursing™
The management of cancer is constantly evolving through the introduction of new developments related to cancer treatment and supportive care. This program will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.
Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (3/9/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress for Community Practices (3/9/2021)

Click the Take Course button to access the evaluation.

 

The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with renal cell carcinoma.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Cutaneous T-Cell Lymphomas
A multidisciplinary team approach involving hematology/oncology, dermatology, and radiation oncology is optimal for the management of patients with MF and SS, particularly those with advanced disease. Informing clinicians about the recommendations outlined in the NCCN Guidelines for Primary Cutaneous Lymphomas for the diagnosis and treatment of MF and SS can help them to develop an individualized treatment plan to improve quality of life and clinical outcomes.

Pages

Subscribe to RSS - Live Webinar